Independent report

Differential pricing for pharmaceuticals: Review of current knowledge, new findings and ideas for action

Pharmaceutical companies, global health donors and other stakeholders have increasingly recognized the need for a careful analysis.

Documents

Differential pricing for pharmaceuticals: Review of current knowledge, new findings and ideas for action

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email enquiry@dfid.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Pharmaceutical companies, global health donors and other stakeholders have increasingly recognized the need for a careful analysis of factors that restrict the use of differential pricing as a mechanism to improve access to medicines in the developing…

Published 1 August 2010